Please login to the form below

Not currently logged in
Email:
Password:

Merz

This page shows the latest Merz news and features for those working in and with pharma, biotech and healthcare.

Merz pulls out of race for Obagi Medical

Merz pulls out of race for Obagi Medical

Merz pulls out of race for Obagi Medical. Leaves Valeant open to complete takeover. ... Obagi was an opportunity worth pursuing given its complementary fit," said Merz chief executive Philip Burchard in a statement.

Latest news

  • Battle lines drawn as Valeant ups Obagi bid Battle lines drawn as Valeant ups Obagi bid

    Battle lines drawn as Valeant ups Obagi bid. Hits back against Merz offer. ... At the time of writing Merz had not issued a response to the new bid.

  • Merz offers $385m to trump Valeant's bid for Obagi Merz offers $385m to trump Valeant's bid for Obagi

    Merz offers $385m to trump Valeant's bid for Obagi. Could spark bidding war for dermatology specialist. ... Our proposal is clearly superior to the Valeant transaction," said Merz in a letter to Obagi's board.

  • Allergan gets US approval for Botox in overactive bladder Allergan gets US approval for Botox in overactive bladder

    The drug remains the dominant force in its category despite competition from rival products Dysport (abobotulinumtoxinA) from Ipsen, Merz' Xeomin (incobotulinumtoxinA) and Solstice Neurosciences' Myobloc (rimabotulinumtoxinB), with Allergan claiming

  • Merz, Lilly and Daiichi-Sankyo breach ABPI code Merz, Lilly and Daiichi-Sankyo breach ABPI code

    Merz, Lilly and Daiichi-Sankyo breach ABPI code. Pharma companies 'named and shamed' for inappropriate marketing in the UK. ... Merz, Lilly and Daiichi-Sankyo have breached the Association of the British Pharmaceutical Industry's (ABPI) Code of Practice

  • GSK’s Tim Brooks joins Creative Leap

    Creative Leap's involvement in the healthcare sector has included working with GSK, Alliance Boots, Bupa, Johnson &Johnson, Merz Aesthetics and also with Reckitt Benckiser.

More from news
Approximately 4 fully matching, plus 20 partially matching documents found.

Latest appointments

  • Ashfield UK makes two new business development appointments Ashfield UK makes two new business development appointments

    Tweedale joins Ashfield after 11 years at Merz Pharma where more recently he served as sales and marketing manager.

  • Bartenbach adds to healthcare management team Bartenbach adds to healthcare management team

    Bartenbach adds to healthcare management team. Anja Treiber has worked with CSL Behring, Novo Nordisk, Fresenius Kabi and Merz Pharma. ... In the last two years, Treiber has focused on international pharma clients including CSL Behring, Novo Nordisk,

  • New VP for Merz North America New VP for Merz North America

    New VP for Merz North America. Gregory Bass to lead market access and reimbursement strategy. ... Bass will be responsible for developing Merz's North American market access and reimbursement strategy to enhance patient access to Merz prescription

More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Ashley Communications

    Allergan: Gastroenterology. Astellas: Urology/Urogynaecology. Blueprint Medicines: Oncology. Indivior: Narcotic Addiction. Merz: Aesthetic Medicine and Neuroscience.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics